Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02937870 · ClinicalTrials.gov registry record · NA
A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive
A NA study of Denture Retention, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT02937870: Completed NA study of Denture Retention, sponsored by GlaxoSmithKline.
NCT02937870 is a NA study of Denture Retention that has completed, run by GlaxoSmithKline. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02937870, a NA study of Denture Retention, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this 4-treatment, 4-period, randomized, crossover, proof of principle bite force study will be to compare bite force measurements over a 12 hour period across two (test) cream denture adhesives, with a currently marketed cream denture adhesive (positive control), and a negative/no treatment control.
Primary Outcome
Area over baseline over 12 hours (AOB0-12) was assessed to measure the incisal bite force. AOB0-12 was calculated as area under the curve over 12 hours \[AUC0-12\])/12 hours minus baseline bite force (pounds \[lbs\]). AUC0-12 was calculated using the trapezoidal method. This transformation returned the measurement to the same scale as the original observations. Higher values of AOB0-12 demonstrate a stronger bite force overtime than lower values.
Conditions Studied
Interventions
- DEVICE Test Product 1
- DEVICE Test Product 2
- DEVICE Reference Product
- OTHER Negative Control
Study Locations (1)
New Jersey
- GSK Investigational Site - Bloomfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-07 |
| Est. Completion | 2017-04-05 |
| Phase | NA |
What the finished NCT02937870 record still lists
NCT02937870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Denture Retention appearing as the primary indexed condition, and to 4 interventions - of which Test Product 1 is the first listed.
NCT02937870 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02937870 about?
NCT02937870 is a clinical study titled "A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive". The objective of this 4-treatment, 4-period, randomized, crossover, proof of principle bite force study will be to compare bite force measurements over a 12 hour period across two (test) cream denture adhesives, with a currently marketed cream denture adhesive (positive control), and a negative/no t...
What is the current status of trial NCT02937870?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-03-07. Estimated completion is 2017-04-05.
What conditions does trial NCT02937870 study?
This clinical trial studies the following conditions: Denture Retention.
What interventions are being tested in trial NCT02937870?
The interventions under investigation include: Test Product 1 (DEVICE), Test Product 2 (DEVICE), Reference Product (DEVICE), Negative Control (OTHER).
Who is sponsoring clinical trial NCT02937870?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02937870 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Denture Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02937870's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI